Kiniksa Pharmaceuticals International, plc Operating Expenses
Kiniksa Pharmaceuticals International, plc (KNSA) reported Operating Expenses of $49.28 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-05-06
- Kiniksa Pharmaceuticals International, plc operating expenses for the quarter ending 2021-03-31 was $49.28M, a 67.70% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc operating expenses for the quarter ending 2020-12-31 was $52.90M, a 62.36% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc operating expenses for the quarter ending 2020-09-30 was $43.22M, a 41.95% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc operating expenses for the quarter ending 2020-06-30 was $31.86M, a 18.91% decline year-over-year.
- Kiniksa Pharmaceuticals International, plc operating expenses for fiscal 2020 was $157.36M, a 7.41% decline from fiscal 2019.
- Kiniksa Pharmaceuticals International, plc operating expenses for fiscal 2019 was $169.96M, a 57.14% increase from fiscal 2018.
- Kiniksa Pharmaceuticals International, plc operating expenses for fiscal 2018 was $108.16M, a 65.38% increase from fiscal 2017.
- Kiniksa Pharmaceuticals International, plc operating expenses for fiscal 2017 was $65.40M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2021-03-31 | $49.28M 10-Q · filed 2021-05-06 | $102.18M derived: sum of 2 quarters · filed 2021-05-06 | $145.40M derived: sum of 3 quarters · filed 2021-05-06 | $177.26M derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | $52.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $96.12M derived: sum of 2 quarters · filed 2021-02-25 | $127.98M derived: sum of 3 quarters · filed 2021-02-25 | $157.36M 10-K · filed 2021-02-25 |
| 2020-09-30 | $43.22M 10-Q · filed 2020-11-05 | $75.08M derived: sum of 2 quarters · filed 2020-11-05 | $104.47M 10-Q · filed 2020-11-05 | $137.05M derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-06-30 | $31.86M 10-Q · filed 2020-08-04 | $61.25M 10-Q · filed 2020-08-04 | $93.83M derived: sum of 3 quarters · filed 2021-05-06 | $124.27M derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-03-31 | $29.39M 10-Q · filed 2021-05-06 | $61.97M derived: sum of 2 quarters · filed 2021-05-06 | $92.41M derived: sum of 3 quarters · filed 2021-05-06 | $131.70M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $32.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $63.03M derived: sum of 2 quarters · filed 2021-02-25 | $102.32M derived: sum of 3 quarters · filed 2021-02-25 | $169.96M 10-K · filed 2021-02-25 |
| 2019-09-30 | $30.45M 10-Q · filed 2020-11-05 | $69.73M derived: sum of 2 quarters · filed 2020-11-05 | $137.38M 10-Q · filed 2020-11-05 | $181.52M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $39.29M 10-Q · filed 2020-08-04 | $106.94M 10-Q · filed 2020-08-04 | $151.07M derived: sum of 3 quarters · filed 2021-02-25 | $177.23M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $67.65M 10-Q · filed 2020-05-04 | $111.78M derived: sum of 2 quarters · filed 2021-02-25 | $137.94M derived: sum of 3 quarters · filed 2021-02-25 | $159.47M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $44.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $70.29M derived: sum of 2 quarters · filed 2021-02-25 | $91.82M derived: sum of 3 quarters · filed 2021-02-25 | $108.16M 10-K · filed 2021-02-25 |
| 2018-09-30 | $26.16M 10-Q · filed 2019-11-05 | $47.69M derived: sum of 2 quarters · filed 2019-11-05 | $64.03M 10-Q · filed 2019-11-05 | $96.74M derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | $21.53M 10-Q · filed 2019-08-13 | $37.87M 10-Q · filed 2019-08-13 | $70.58M derived: sum of 3 quarters · filed 2019-08-13 | $86.83M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $16.34M 10-Q · filed 2019-05-07 | $49.05M derived: sum of 2 quarters · filed 2019-05-07 | $65.30M derived: sum of 3 quarters · filed 2019-05-07 | $76.69M derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | $32.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $48.96M derived: sum of 2 quarters · filed 2019-03-12 | $60.35M derived: sum of 3 quarters · filed 2019-03-12 | $65.40M 10-K · filed 2019-03-12 |
| 2017-09-30 | $16.25M 10-Q · filed 2018-11-06 | $27.64M derived: sum of 2 quarters · filed 2018-11-06 | $32.69M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $11.39M 10-Q · filed 2018-08-06 | $16.44M 10-Q · filed 2018-08-06 |